Evidence map›Paper›PMID 27230768›Full record

ArticleEndocrine2017

How do etiological factors can explain the different clinical features of patients with differentiated thyroid cancer and their histopathological findings?

Loredana Pagano, Chiara Mele, Debora Arpaia, Maria Teresa Samà, Marina Caputo, Serena Ippolito, Carmela Peirce, Flavia Prodam, Guido Valente, Giuseppe Ciancia and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Endocrine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Loredana PaganoDepartment of Translational Medicine, University of Eastern Piedmont, Via Solaroli 17, 28100, Novara, Italy. loredana.pagano@med.uniupo.it.
Chiara MeleDepartment of Translational Medicine, University of Eastern Piedmont, Via Solaroli 17, 28100, Novara, Italy.
Debora ArpaiaDepartment of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Maria Teresa SamàDepartment of Translational Medicine, University of Eastern Piedmont, Via Solaroli 17, 28100, Novara, Italy.
Marina CaputoDepartment of Translational Medicine, University of Eastern Piedmont, Via Solaroli 17, 28100, Novara, Italy.
Serena IppolitoDepartment of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Carmela PeirceDepartment of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Flavia ProdamDepartment of Health Sciences, University of Eastern Piedmont, Novara, Italy.
Guido ValenteDepartment of Translational Medicine, University of Eastern Piedmont, Via Solaroli 17, 28100, Novara, Italy.
Giuseppe CianciaDepartment of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.
Gianluca AimarettiDepartment of Translational Medicine, University of Eastern Piedmont, Via Solaroli 17, 28100, Novara, Italy.
Bernadette BiondiDepartment of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim was to retrospectively analyse the clinical-histopathological characteristics of patients with newly diagnosis of differentiated thyroid cancer (DTC) referred to two Italian centres, one in Northern and the other in Southern Italy, between 2000 and 2013. 1081 patients were included and subdivided into two groups: group A (474 patients from Novara) and group B (607 patients from Naples). The group A came from the industrial area of Novara, while the Group B came from the areas around Vesuvius and Campi Flegrei. The two groups were comparable for iodine levels, body mass index, diagnostic timing and clinical procedures. For all patients, demographic and clinical data were collected. No difference was found in gender, whereas the age at diagnosis was later in the group A (group A 53.1 ± 15.16 years, group B 41.9 ± 14.25 years, p < 0.001). In both groups, the most frequent histotype was papillary thyroid cancer (PTC) with prevalence of follicular variant in group A (p < 0.0001) and classical variant in group B (p < 0.0001). Aggressive histological features were mainly seen in group A (bilaterality p < 0.0001, multifocality p < 0.0001 and thyroid capsular invasion p < 0.0001). Microcarcinomas were more frequent in group A (p < 0.0001) but mostly characterized by bilaterality (p < 0.001) and multifocality (p < 0.04). In both groups, tumour-associated thyroiditis showed a significant increase over the years (group A p < 0.05, group B p < 0.04). Environmental factors could justify the differences found in our study. These preliminary data should stimulate the need for an Italian Cancer Registry of DTC in order to allow an epidemiological characterization, allowing the identification of specific etiological factors and an improvement in the management of the disease.

Indexed as

AdultAgedBody Mass IndexCarcinogenesisCarcinoma, PapillaryCarcinoma, Papillary, FollicularFemaleHumansItalyMaleMiddle AgedRetrospective StudiesThyroid GlandThyroid NeoplasmsClinical–histopathological featuresEnvironmental factorsThyroid cancerTumourigenesis induction

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.